重症监护病房肺部感染鲍氏不动杆菌的耐药性分析

目的分析鲍曼不动杆菌肺部感染的临床特点及耐药性,为临床医师诊断和治疗提供依据。方法对2006年10月至2010年10月期间,ICU及神经外科重症监护病房住院患者确诊为肺部感染的呼吸道标本中分离的鲍曼不动杆菌324株,采用K-B法进行药敏试验,结果判定按CLSI标准。结果对常用抗菌药物耐药性逐年增加,头孢哌酮/舒巴坦耐药率最低为16.5%,其次为亚胺培南19.8%和美罗培南24.4%,对其余13种抗菌药物的耐药率均在46.4%～96.4%。结论临床对鲍氏不动杆菌引起医院感染应高度重视,应合理应用抗菌药物以减少耐药菌株的产生。

Drug resistance analysis of lung infection Acinetobacter baumannii in intensive care unit

Objective Analyze the clinical distribution and drug resistance of Acinetobacter baumannii in lung infection,to provide the scientific evidence for clinical diagnosis and treatment.Methods We conducted a survey of pathogenic bacteria which isolated from the patient lung infection in intensive care unit and Neurosurgrical intensive care unite from Oct.2006 to Oct.2010,324 Acinetobacter baumannii were isolated.Drug sensitivity experiment was performed by Kirby-Bauer method.The results were determined accordin...